Full text loading...
Three previously uncharacterized bacterial species, designated strains BD586T, BD613T and BD626T, isolated from human clinical specimens, were identified at Mayo Clinic, Rochester, Minnesota, USA. Initial identification efforts using matrix-assisted laser desorption ionization-time-of-flight MS and partial 16S rRNA gene sequencing proved inconclusive. Comprehensive analysis involving phenotypic characterization, biochemical assays and whole-genome sequencing was undertaken. The isolates were Gram-negative, motile, facultatively anaerobic rods, occurring singly, in pairs and in short chains; BD613T additionally formed small aggregates. The isolates tested positive for catalase and negative for oxidase. Their colonies appeared smooth, white, opaque and non-haemolytic. Growth was observed at 35 °C under aerobic, anaerobic and CO₂-enriched conditions, as well as in media with NaCl concentrations up to 10% and at pH 7-9. Phylogenetic relationships were inferred from core gene alignments, average nucleotide identity and digital DNA–DNA hybridization comparisons. Results confirmed the placement of BD586T, BD613T and BD626T within the recently established Dryocola genus, while also indicating their novelty as distinct species. The major cellular fatty acids were C16:0 and C17:0 cyclo. Based on these findings, a formal description of three new species, Dryocola mayonis sp. nov. (type strain BD586T=TSD 474T, =NCTC 15089T, =DSM 119465T), Dryocola sharpae sp. nov. (type strain BD613T=TSD 475T, =NCTC 15090T, =DSM 119466T) and Dryocola baronae sp. nov. (type strain BD626T=TSD 476T, =NCTC 15091T, =DSM 119479T), is proposed, and the genus description of Dryocola is emended to refine its genomic, morphological and chemotaxonomic boundaries.